Both in Pharmaceuticals
Maravai LifeSciences Holdings vs Savara
Over the past year MRVI returned +124.6% and SVRA returned +10.4%; their daily moves had a correlation of 0.21.
MRVI +124.6% SVRA +10.4%Growth of $1, one year, split-adjusted
| Metric | MRVI | SVRA |
|---|---|---|
| Price | $7.57 | $4.67 |
| Market cap | $1.13B | $959.5M |
| Today | +5.14% | −1.89% |
| 1 month | +1.5% | −11.9% |
| 6 months | +105.1% | −9.1% |
| Year to date | +132.9% | −22.6% |
| 1 year | +115.1% | +13.6% |
| Revenue growth (YoY) | +8.5% | — |
| Gross margin | 40.1% | — |
| Net margin | −24.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 5.4× | — |
| Net cash | -$106.6M | $142.9M |
| Dividend yield | — | — |
| Volatility (60d) | 80.4% | 43.2% |
| Short % of float | 11.1% | 30.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).